Abstract:PURPOSE:The increase in fructose consumption is paralleled by a higher incidence of obesity worldwide. This monosaccharide is linked to metabolic syndrome, being associated with hypertriglyceridemia, hypertension, insulin resistance and diabetes mellitus. It is metabolized principally in the liver, where it can be converted into fatty acids, which are stored in the form of triglycerides leading to NAFLD. Several models of NAFLD use diets high in simple carbohydrates. Thus, this study aimed to describe the majo… Show more
“…NAFLD is strongly associated with obesity and insulin resistance and is currently conceptualised as the hepatic manifestation of metabolic syndrome (MS) . Growing evidence suggests that the fast‐growing and alarming epidemic of NAFLD is closely intertwined with the Westernisation of dietary patterns with an increasing intake of simple sugars, especially fructose …”
Section: Introductionmentioning
confidence: 99%
“…Starting from the 1960s, a number of animal and human studies have reported associations with excessive fructose consumption and adverse metabolic effects, which may have important hepatic consequences (including the development of NAFLD). The potential role of fructose in the pathogenesis of NAFLD has thus recently gained mounting attention and has been previously reviewed in detail . However, the extent to which fructose consumption is playing a role in liver damage and failure has not yet been investigated fully.…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8] Growing evidence suggests that the fast-growing and alarming epidemic of NAFLD is closely intertwined with the Westernisation of dietary patterns with an increasing intake of simple sugars, especially fructose. [9][10][11][12][13][14] Fructose is an isomer of glucose with a hydroxyl group on carbon-4 reversed in position. 15 Recent decades have witnessed an enormous rise in fructose consumption.…”
SUMMARY BackgroundThe role of excess fructose intake in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) has recently received increasing attention, but the pathophysiology of this relationship has been only partly elucidated.
AimTo provide an overview of the potential role played by fructose in the pathogenesis of NAFLD by focusing on both indirect and direct harmful effects.
MethodsExperimental and clinical studies which investigated the relation of fructose with NAFLD are reviewed.
ResultsSeveral factors may potentially contribute to fructose-induced NAFLD, including the induction of the metabolic syndrome, copper deficiency, bacterial translocation from the gut to the liver, the formation of advanced glycation endproducts and a direct dysmetabolic effect on liver enzymes.
ConclusionsExperimentally-increased fructose intake recapitulates many of the pathophysiological characteristics of the metabolic syndrome in humans, which may in turn lead to NAFLD. However, the majority of experimental studies tend to involve feeding excessively high levels of fructose (60-70% of total energy intake) which is not reflective of average human intake. Hopefully, the combination of in vivo, in vitro and genetic research will provide substantial mechanistic evidence into the role of fructose in NAFLD development and its complications.
“…NAFLD is strongly associated with obesity and insulin resistance and is currently conceptualised as the hepatic manifestation of metabolic syndrome (MS) . Growing evidence suggests that the fast‐growing and alarming epidemic of NAFLD is closely intertwined with the Westernisation of dietary patterns with an increasing intake of simple sugars, especially fructose …”
Section: Introductionmentioning
confidence: 99%
“…Starting from the 1960s, a number of animal and human studies have reported associations with excessive fructose consumption and adverse metabolic effects, which may have important hepatic consequences (including the development of NAFLD). The potential role of fructose in the pathogenesis of NAFLD has thus recently gained mounting attention and has been previously reviewed in detail . However, the extent to which fructose consumption is playing a role in liver damage and failure has not yet been investigated fully.…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8] Growing evidence suggests that the fast-growing and alarming epidemic of NAFLD is closely intertwined with the Westernisation of dietary patterns with an increasing intake of simple sugars, especially fructose. [9][10][11][12][13][14] Fructose is an isomer of glucose with a hydroxyl group on carbon-4 reversed in position. 15 Recent decades have witnessed an enormous rise in fructose consumption.…”
SUMMARY BackgroundThe role of excess fructose intake in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) has recently received increasing attention, but the pathophysiology of this relationship has been only partly elucidated.
AimTo provide an overview of the potential role played by fructose in the pathogenesis of NAFLD by focusing on both indirect and direct harmful effects.
MethodsExperimental and clinical studies which investigated the relation of fructose with NAFLD are reviewed.
ResultsSeveral factors may potentially contribute to fructose-induced NAFLD, including the induction of the metabolic syndrome, copper deficiency, bacterial translocation from the gut to the liver, the formation of advanced glycation endproducts and a direct dysmetabolic effect on liver enzymes.
ConclusionsExperimentally-increased fructose intake recapitulates many of the pathophysiological characteristics of the metabolic syndrome in humans, which may in turn lead to NAFLD. However, the majority of experimental studies tend to involve feeding excessively high levels of fructose (60-70% of total energy intake) which is not reflective of average human intake. Hopefully, the combination of in vivo, in vitro and genetic research will provide substantial mechanistic evidence into the role of fructose in NAFLD development and its complications.
“…NAFLD is a common liver disease usually occurring in patients that do not habitually consume alcohol and manifesting as an excessive accumulation of triglycerides in the liver, leading to fat build-up and an increase in total liver weight of over 5%. The prevalence of fatty liver in obese and diabetic patients can reach 70–90% [2]. Fatty liver occurs either as simple steatosis (hepatic steatosis) or in combination with non-alcoholic liver inflammation.…”
Hepatic manifestations of the metabolic syndrome are related obesity, type 2 diabetes/insulin resistance and non-alcoholic fatty liver disease. Here we investigated how the anti-inflammatory properties of lactoferrin can protect against the onset of hepatic manifestations of the metabolic syndrome by using a murine model administered with high-fructose corn syrup. Our results show that a high-fructose diet stimulates intestinal bacterial overgrowth and increases intestinal permeability, leading to the introduction of endotoxin into blood circulation and liver. Immunohistochemical staining of Toll-like receptor-4 and thymic stromal lymphopoietin indicated that lactoferrin can modulate lipopolysaccharide-mediated inflammatory cascade. The important regulatory roles are played by adipokines including interleukin-1β, interleukin-6, tumor necrosis factor-α, monocyte chemotactic protein-1, and adiponectin, ultimately reducing hepatitis and decreasing serum alanine aminotransferase release. These beneficial effects of lactoferrin related to the downregulation of the lipopolysaccharide-induced inflammatory cascade in the liver. Furthermore, lactoferrin reduced serum and hepatic triglycerides to prevent lipid accumulation in the liver, and reduced lipid peroxidation, resulting in 4-hydroxynonenal accumulation. Lactoferrin reduced oral glucose tolerance test and homeostasis model assessment-insulin resistance. Lactoferrin administration thus significantly lowered liver weight, resulting from a decrease in the triglyceride and cholesterol synthesis that activates hepatic steatosis. Taken together, these results suggest that lactoferrin protected against high-fructose corn syrup induced hepatic manifestations of the metabolic syndrome.
“…A primeira opção leva cerca de 90 dias para induzir o diabete, com resultados variáveis. Já a aloxana e a estreptozocina levam 24h para a indução do diabete (Castro et al, 2011).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.